HCA Healthcare, Inc. HCA
Set alert
At close · Oct 30
After hours · Oct 30, 6:17 PM ET
- YTD
- +1.36%
- 1 year
- +1.37%
- Open
- 480.34
- Prev close
- 478.08
- Mkt cap
- 104.97B
- Vol
- 1.12M
- Avg vol
- 1.32M
- EPS
- 30.15
- P/E
- 15.69
- Div yield
- 0.65%
More statistics
- Low
- 472.46
- High
- 485.73
- Forward P/E
- 15.13
- Beta
- 1.11
- Short ratio
- 3.70
- Inst. own
- 78.74%
- Dividend
- 3.12
- Ex-div date
- Dec 14, 2026
- Earnings
- Jan 26, 2027
- 50-d avg
- 436.07
- 200-d avg
- 444.42
- 1y target
- 469.91
5D chart
Events in this range
- Oct 27, 2026Earnings: 7.22; estimate 6.65; surprise 8.57%
- Oct 28, 2026Rating: B of A Securities · Neutral → Neutral
- Oct 28, 2026Rating: Baird · Neutral → Neutral
- Oct 28, 2026Rating: Keybanc · Overweight → Overweight
- Oct 28, 2026Rating: TD Cowen · Buy → Buy
- Oct 29, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 30, 2026Rating: RBC Capital · Outperform → Outperform
Signals (126)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 3:40 PM | 2 days ago |
| RSI: Oversold | Oct 30, 3:10 PM | 2 days ago |
| RSI: Oversold | Oct 30, 3:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:20 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:55 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:45 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:20 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:15 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:10 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 2 days ago |
| RSI: Overbought | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:40 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:45 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:50 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:45 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:45 AM | 4 days ago |
| RSI: Overbought | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:05 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:05 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:40 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:25 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:20 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 6 days ago |
| RSI: Oversold | Oct 26, 1:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:25 PM | 6 days ago |
| RSI: Oversold | Oct 26, 12:50 PM | 6 days ago |
| RSI: Oversold | Oct 26, 12:10 PM | 6 days ago |
| RSI: Oversold | Oct 26, 11:55 AM | 6 days ago |
| RSI: Oversold | Oct 26, 11:40 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
News
2 days ago benzinga.com
Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street
Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
-
2 days ago benzinga.com
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.
-
3 days ago benzinga.com
Barclays Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $401
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $387 to $401.
3 days ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
3 days ago businesswire.com
More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades…
-
4 days ago benzinga.com
TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $486
TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $460 to $486.
4 days ago seekingalpha.com
HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track
HCA Healthcare, Inc. is reiterated at Hold, with shares trading near fair value and a mixed technical outlook. Q3 results beat expectations: non-GAAP EPS of $7.22 and revenue of $19.9B, driven by…
4 days ago benzinga.com
HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results
HCA Healthcare Inc. (NYSE:HCA) on Tuesday posted upbeat third-quarter results.
4 days ago benzinga.com
HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results
HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.
-
4 days ago benzinga.com
Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.
-
4 days ago benzinga.com
Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.
-
4 days ago benzinga.com
B of A Securities Maintains Neutral on HCA Healthcare, Raises Price Target to $500
B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $450 to $500.
4 days ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
5 days ago seekingalpha.com
HCA Healthcare, Inc. (HCA) Q3 2026 Earnings Call Transcript
HCA Healthcare, Inc. ( HCA ) Q3 2026 Earnings Call October 27, 2026 10:00 AM EDT Company Participants Frank Morgan - Vice President of Investor Relations Samuel Hazen - CEO & Director Mike Marks -…
5 days ago marketbeat.com
What HCA Healthcare (HCA) Said on Its Q3 Earnings Call
HCA Healthcare NYSE: HCA said third-quarter results modestly exceeded its expectations as admissions growth, improved insured revenue per admission and disciplined cost management helped offset…
5 days ago zacks.com
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
HCA's Q3 earnings and revenues beat estimates on higher admissions and ER visits, while rising costs and fewer surgeries temper growth.
5 days ago benzinga.com
HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock
U.S.-based hospital HCA Healthcare Inc. (NYSE:HCA) released third-quarter 2026 revenues of $19.849 billion, representing a 3.6% year-over-year increase, beating the consensus estimate of $19.332…
5 days ago benzinga.com
HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock
HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
5 days ago zacks.com
HCA (HCA) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street…
5 days ago benzinga.com
HCA Healthcare Q3 2026 Earnings Call Transcript
HCA Healthcare (NYSE:HCA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
5 days ago zacks.com
HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $7.22 per share, beating the Zacks Consensus Estimate of $6.74 per share. This compares to earnings of $6.96 per share a year ago.
5 days ago gurufocus.com
HCA Healthcare Reports Third Quarter 2026 Results
[url="]HCA Healthcare, Inc.[/url] (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026.Key third quarter m
5 days ago wsj.com
HCA Healthcare Profit Slips but Revenue Rises
The operator of healthcare facilities on posted net income of $1.58 billion, compared with $1.64 billion in the same quarter a year ago.
-
5 days ago benzinga.com
HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est
HCA Healthcare (NYSE:HCA) raises FY2026 GAAP EPS guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 analyst estimate. Raises FY2026 sales outlook from $77.000 billion-$79.500 billion to $78.250…
5 days ago businesswire.com
HCA Healthcare Reports Third Quarter 2026 Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all…
5 days ago defenseworld.net
HCA Healthcare, Inc. $HCA Stock Bought by Hourglass Capital LLC
Hourglass Capital LLC increased its stake in HCA Healthcare, Inc. (NYSE: HCA) by 14.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission.…
6 days ago benzinga.com
Visa, Coca-Cola On Deck Tuesday As Payments Growth, Global Demand Face Test
Visa is Tuesday’s most material report, with investors looking for continued payments growth after a strong run in the stock. Coca-Cola, HSBC Holdings, Novartis, Boeing and S&P Global report before…
6 days ago zacks.com
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
1 week ago zacks.com
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
1 week ago zacks.com
Countdown to HCA (HCA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of HCA (HCA) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics…
1 week ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
1 week ago zacks.com
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?
HCA's Q3 results could benefit from higher admissions, occupancy and inpatient revenues, but rising costs and fewer outpatient surgeries cloud the outlook.
-
2 weeks ago benzinga.com
TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $460
TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $431 to $460.
-
3 weeks ago benzinga.com
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.
-
3 weeks ago benzinga.com
FTC Issues Letters Warning Hospitals Against Deceptive Pricing Practices
https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-issues-letters-warning-hospitals-against-deceptive-pricing-practices
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 month ago benzinga.com
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
-
1 month ago benzinga.com
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495
BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.
-
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
1 month ago benzinga.com
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.
-
2 months ago benzinga.com
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425
JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.
2 months ago benzinga.com
Jim Cramer Looked At This 'Not Great' Uranium Stock 'For Years'
CNBC's Jim Cramer offers his takes on various companies, including CME Group, Alcoa, Rocket Lab, Fortinet, HCA Healthcare and Hubbell.
-
3 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381
Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $369 to $381.
-
3 months ago benzinga.com
Goldman Sachs Maintains Buy on HCA Healthcare, Lowers Price Target to $485
Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $558 to $485.
-
3 months ago benzinga.com
Mizuho Maintains Outperform on HCA Healthcare, Lowers Price Target to $475
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $525 to $475.
3 months ago benzinga.com
This Congressman Slammed Elon Musk — Then Bought SpaceX Stock
Multiple members of Congress disclose buying SpaceX stock, even some who aren't big fans of Elon Musk.
-
3 months ago benzinga.com
UBS Maintains Buy on HCA Healthcare, Lowers Price Target to $579
UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $635 to $579.
3 months ago benzinga.com
Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind
HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in surgeries.
-
3 months ago benzinga.com
Morgan Stanley Maintains Underweight on HCA Healthcare, Lowers Price Target to $380
Morgan Stanley analyst Craig Hettenbach maintains HCA Healthcare (NYSE:HCA) with a Underweight and lowers the price target from $425 to $380.
3 months ago benzinga.com
HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of $7.59 per share. Analysts lower price targets.